Sonographic Features of Rectus Femoris Muscle in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Their Correlation with Body Composition Parameters and Muscle Strength: Results of a Single-Center Cross-Sectional Study

被引:0
|
作者
Sheptulina, Anna F. [1 ]
Yafarova, Adel A. [1 ]
Mamutova, Elvira M. [1 ]
Drapkina, Oxana M. [1 ,2 ]
机构
[1] Natl Med Res Ctr Therapy & Prevent Med, Dept Fundamental & Appl Aspects Obes, Moscow 101990, Russia
[2] AI Evdokimov Moscow State Univ Med & Dent, Dept Therapy & Prevent Med, Moscow 127473, Russia
基金
俄罗斯科学基金会;
关键词
ultrasound; skeletal muscles; dual-energy X-ray absorptiometry; bioimpedance analysis; metabolic dysfunction-associated steatotic liver disease; BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; SARCOPENIC OBESITY; OLDER-ADULTS; ULTRASOUND; DISCORDANCE; RELIABILITY; DIAGNOSIS; ELASTOGRAPHY; DEFINITION;
D O I
10.3390/biomedicines12081684
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to describe sonographic features of rectus femoris muscle (RFM) in patients with metabolic dysfunction-associated fatty liver disease (MASLD) and their correlation with body composition parameters and muscle strength. A total of 67 patients with MASLD underwent dual-energy X-ray absorptiometry (DEXA), bioimpedance analysis (BIA), muscle strength measurement (grip strength [GS] and chair stand test [CST]), and ultrasound (US) investigation of the RFM in the dominant thigh using a 4 to 18 MHz linear probe. MASLD patients exhibited increased RFM echogenicity, possibly due to fatty infiltration. We confirmed that the greater the subcutaneous fat thickness, the smaller was the muscle mass (p < 0.001), and the lower was the muscle strength (p < 0.001 for GS and p = 0.002 for CST). On the contrary, the greater the anteroposterior diameter (APD) of RFM, the higher was the muscle mass (p < 0.001), and the greater was the muscle strength (p < 0.001 for GS and p = 0.007 for CST). In addition, APD of the RFM and stiffness of RFM exhibited direct correlation with bone mineral density values of the lumbar spine (p = 0.005 for both GS and CST). We concluded that US investigation of the RFM in the dominant thigh can be helpful in identifying MASLD patients at a high risk of musculoskeletal disorders given repeated point-of-care clinical evaluations.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Is Associated with Cervical Stromal Involvement in Endometrial Cancer Patients: A Cross-Sectional Study in South China
    Lin, Xite
    Chen, Chunxia
    Jiang, Tingting
    Ma, Jincheng
    Huang, Lixiang
    Huang, Leyi
    Lei, Huifang
    Tong, Yao
    Huang, Guanxiang
    Mao, Xiaodan
    Sun, Pengming
    CURRENT ONCOLOGY, 2023, 30 (04) : 3787 - 3799
  • [22] Metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with Inflammatory Bowel Disease (IBD). A prospective single-center study
    Pastras, P.
    Papantoniou, K.
    Tsounis, E.
    Kanaloupitis, S.
    Aggeletopoulou, I
    Geramoutsos, G.
    Sotiropoulos, C.
    Zisimopoulos, K.
    Thomopoulos, K.
    Theocharis, G.
    Triantos, C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2289 - i2289
  • [23] Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study
    Liu, Huanxin
    Xing, Yuling
    Nie, Qian
    Li, Zhong
    Meng, Cuiqiao
    Ma, Huijuan
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2153 - 2163
  • [24] Association between carotenoid intake and metabolic dysfunction-associated fatty liver disease among US adults: A cross-sectional study
    Zhang, Hang
    Li, Li
    Jia, Lei
    Liu, Jinchun
    MEDICINE, 2023, 102 (51) : E36658
  • [25] Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study
    Cui, Junfang
    Liu, Yunfeng
    Li, Mina
    Yin, Jianhong
    Yang, Jing
    Xu, Linxin
    BMC ENDOCRINE DISORDERS, 2024, 24 (01)
  • [26] Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort
    Zou, Yao-Wei
    Li, Qian-Hua
    Gao, Jing-Wei
    Pan, Jie
    Ma, Jian-Da
    Chen, Le-Feng
    Lin, Jian-Zi
    Mo, Ying-Qian
    Zhang, Xue-Pei
    Liu, Pin-Ming
    Dai, Lie
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [27] Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study
    Junfang Cui
    Yunfeng Liu
    Mina Li
    Jianhong Yin
    Jing Yang
    Linxin Xu
    BMC Endocrine Disorders, 24
  • [28] Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018
    Mai, Zhiliang
    Chen, Yinfei
    Mao, Hua
    Wang, Lisheng
    JOURNAL OF DIABETES, 2024, 16 (06)
  • [29] Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients: A Cross-Sectional Study
    Sezer, Semih
    Demirci, Selim
    Kara, Murat
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2025, 36 (03):
  • [30] RISK FACTORS ASSOCIATED WITH DECREASED BONE MINERAL DENSITY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A CROSS-SECTIONAL STUDY AT A HEALTH EXAMINATION CENTER
    Yokoyama, Shinya
    Honda, Takashi
    Yamamoto, Kenta
    Ito, Takanori
    Imai, Norihiro
    Ishizu, Yoji
    Mizuno, Kazuyuki
    Kojima, Tetsuhito
    Kariya, Naoyoshi
    Kawashima, Hiroki
    HEPATOLOGY, 2024, 80 : S552 - S553